HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sclerotherapy of reticular and telangiectatic veins of the face, hands, and chest.

AbstractBACKGROUND:
Prominent tortuous veins of the face and hands may result from the process of aging and constitute a source of distress for many patients. Marked telangiectases of the chest and face are similarly distressing to some patients.
OBJECTIVE:
To determine the safety and efficacy of sclerotherapy for telangiectatic veins of the face and chest and varicose veins of the hands.
METHODS:
Twenty facial telangiectases and tortuous veins in 14 patients and 20 total facial sites were treated with sclerotherapy. Patients did not suffer from collagen vascular diseases, had no chronic illnesses, and were thoroughly informed of the strictly cosmetic nature of the procedure. A hyperosmolar sclerosant was used in 16 of 20 sites and the remaining 4 sites were treated with a detergent sclerosant (polidocanol 0.5-0.75%). The follow-up period ranged from 9 months to 15 years. Similarly the varicose veins of 14 hands in seven patients were treated with sclerotherapy using a detergent sclerosant [sodium tetradecyl sulfate (STS)] at various concentrations (1-3%). The follow-up period ranged from 1 to 6.5 years. Tortuous veins and telangiectases on the chest of three patients were treated with either STS 0.25-0.50% or polidocanol 0.75% with a follow-up of 2-9 years.
RESULTS:
Tortuous facial veins and telangiectases had a mean improvement of 70%, with 11 of 20 sites showing a 90-100% improvement. Hand varicosities had a mean improvement of 97.8%, and all sites showed a 90-100% resolution of varicosities. Finally, the tortuous veins and telangiectases of the chest improved by 50-100% with sclerotherapy. Only minimal to moderate telangiectatic matting was observed in two patients (one in the lateral canthal area and one near the treatment site of chest reticular veins). No ulceration or hyperpigmentation occurred long term in facial or hand veins. One patient developed an arterial ulceration on the left lateral breast.
CONCLUSION:
Sclerotherapy of varicose and telangiectatic veins of the face, hands, and chest can be safe and effective. Care must be given to sclerotherapy in the chest area, particularly the breast.
AuthorsLeyda E Bowes, Mitchel P Goldman
JournalDermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] (Dermatol Surg) Vol. 28 Issue 1 Pg. 46-51 (Jan 2002) ISSN: 1076-0512 [Print] United States
PMID11991270 (Publication Type: Journal Article)
Chemical References
  • Sclerosing Solutions
  • Sodium Tetradecyl Sulfate
Topics
  • Adult
  • Face (blood supply)
  • Female
  • Follow-Up Studies
  • Hand (blood supply)
  • Humans
  • Male
  • Middle Aged
  • Sclerosing Solutions (administration & dosage)
  • Sclerotherapy (methods)
  • Sodium Tetradecyl Sulfate (administration & dosage)
  • Telangiectasis (therapy)
  • Thorax (blood supply)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: